Boehringer Snaps Up T3 Amid Broader Immuno-Oncology Push

 
• By Alaric DeArment
  
Boehringer Ingelheim said it would spend up to CHF450m to acquire T3 Pharma • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Deals

More from Business